AKY-1189 — Topline data
Q1 2027
Preliminary data from Part 1 of the ongoing Phase 1b clinical trial are expected in the first quarter of 2027.Source filing
AKTIS ONCOLOGY INC · Data as of 2026-09-08
Q1 2027
Preliminary data from Part 1 of the ongoing Phase 1b clinical trial are expected in the first quarter of 2027.Source filing
2027
Expect preliminary data from Phase 1b mCRPC clinical trial in 2027.Source filing